Information Provided By: 
Fly News Breaks for April 3, 2018
ANGO
Apr 3, 2018 | 09:31 EDT
As previously reported, Raymond James analyst Jayson Bedford upgraded AngioDynamics to Outperform from Market Perform, with a $21 price target, based on a combination of attractive valuation on a stock that has been a chronic underperformer, an inflection in gross margins, which offers cushion to his earnings estimates, and his view that management should engage in more active portfolio management, which has the potential to unlock value in a stock.
News For ANGO From the Last 2 Days
There are no results for your query ANGO
